Publications

Résultats 301 à 310 sur 563 Publications
Titre Auteurs
Chercheurs du CCNV* / Stagiaires du CCNV**
Année Revue
FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions
Qamar S., Wang G., Randle S.J., Ruggeri F.S., Varela J.A., Lin J.Q., Phillips E.C., Miyashita A., Williams D., Strohl F., Meadows W., Ferry R., Dardov V.J., Tartaglia G.G., Farrer L.A., Kaminski Schierle G.S., Kaminski C.F., Holt C.E., Fraser P.E., Schmitt-Ulms G., Klenerman D., Knowles T., Vendruscolo M., St George-Hyslop P. Cell
Full sequencing and haplotype analysis of MAPT in Parkinson’s disease and rapid eye movement sleep behavior disorder Li, J., Ruskey, J.A., Arnulf, I., Dauvilliers, Y., Hu, M.T.M., Hogl, B., Leblond, C.S., Zhou, S., Ambalavanan, A., Ross, J.P., Bourassa, C.V., Spiegelman, D., Laurent, S.B., Stefani, A., Charley Monaca, C., Cochen De Cock, V., Boivin, M., Ferini-Strambi, L., Plazzi, G., Antelmi, E., Young, P., Heidbreder, A., Labbe, C., Ferman, T.J., Dion, P.A., Fan, D., Desautels, A., Gagnon, J.F., Dupre, N., Fon, E.A., Montplaisir, J.Y., Boeve, B.F., Postuma, R.B., Rouleau, G.A., Ross, O.A., & Gan-Or, Z. 2018 Movement Disorders
Frequency of loss of function variants in LRRK2 in Parkinson Disease Blauwendraat, C., Reed, X., Kia, D.A., Gan-Or, Z., Lesage, S., Pihlstrom, L., Guerreiro, R., Gibbs, J.R., Sabir M., Ahmed, S., Ding, J., Alcalay, R.N., Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease. Hassin-Baer, S., Pittma,n A.M., Brooks, J., Edsall, C., Hernandez, D.G., Chung, S.J., Goldwurm, S., Toft, M., Schulte, C., Bras, J., Wood, N.W., Brice, A., Morris, H.R., Scholz, S.W., Nalls, M.A., Singleton, A.B., Cookson, M.R., for the COURAGE-PD Consortium, the French Parkinson's Disease Consortium, & the International Parkinson's Disease Genomics Consortium. 2018 JAMA Neurology
Frailty, lifestyle, genetics and dementia risk
Ward, D. D., Ranson, J. M., Wallace, L.**, Llewellyn, D. J., & Rockwood, K.* 2021 Journal of Neurology, Neurosurgery, and Psychiatry
Frailty Prevalence in the COMPASS-ND Study of Neurodegenerative Disorders
Burt JR*, Godin J*, Filion J**, Montero-Odasso M**, Rockwood K**, Andrew MK**, Camicioli R** 2019 Canadian Geriatrics Journal
Frailty is associated with the clinical expression of neuropsychological deficits in older adults
Canevelli, M., Wallace, L. M. K., Bruno, G., Cesari, M., Rockwood, K.*, & Ward, D. D. 2023 European journal of neurology
Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer’s genetic risk
Thibeau S, McDermott KL, McFall GP, Rockwood K, Dixon RA 2019 Alzheimer's Research & Therapy
Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer’s disease
Xhima K, Markham-Coultes K, Nedev H, Helnen S, Saragovi HU**, Hynynen K, Aubert I. 2020 Sciences Advances
Fluid and imaging biomarkers for Alzheimer’s disease: Where we stand and where to head to Henriques A.D., Benedet A.L., Camargos E.F., Rosa-Neto P., Nobrega O.T. 2018 Experimental Gerontology
FLAIR MRI Biomarkers of the Normal Appearing Brain Matter are Related to Cognition
Bahsoun, M. A., Khan, M. U., Mitha, S., Ghazvanchahi, A., Khosravani, H., Jabehdar Maralani, P., Tardif, J. C., Moody, A. R., Tyrrell, P. N., & Khademi, A.* 2022 NeuroImage Clinical
Résultats 301 à 310 sur 563 Publications
Go back to top